Sign In
Buy MRSN
$29.08
+0 (+0%)
At Close: Apr 02, 2026
MAITLAND, Fla.--(BUSINESS WIRE)--Advanced Dermatology and Cosmetic Surgery (ADCS), a national leader in dermatology care, today announced that Justin Simoncini has been promoted to Chief Strategy Offi
Stoke Therapeutics Announces Appointment of Garry E. Menzel, Ph.D., to its Board of Directors
11:30am, Monday, 17'th Aug 2020
Stoke Therapeutics, Inc., (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced t
Did Hedge Funds Make The Right Call On Mersana Therapeutics, Inc. (MRSN) ?
04:25pm, Tuesday, 11'th Aug 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
Affimed N.V. (AFMD) CEO Adi Hoess on Q2 2020 Results - Earnings Call Transcript
03:41pm, Tuesday, 11'th Aug 2020
Affimed N.V. (NASDAQ:AFMD) Q2 2020 Earnings Conference Call August 11, 2020 8:30 a.m.
CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-dr
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
11:30am, Monday, 10'th Aug 2020
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today reported fin
Recap: Mersana Therapeutics Q2 Earnings
11:17am, Friday, 07'th Aug 2020
Shares of Mersana Therapeutics (NASDAQ:MRSN) remained unaffected after the company reported Q2 results.Quarterly Results Earnings per share were up 8.33% year over year to ($0.33), which missed the es
Mersana Therapeutics Announces Second Quarter 2020 Financial Results and Provides Business Update
10:00am, Friday, 07'th Aug 2020
- Presented positive interim expansion cohort data from XMT-1536 Phase 1 study at ASCO demonstrating a 35% objective response rate, including 10% complete response rate and 80% disease control rate in
The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs
12:00am, Friday, 07'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 6)
ADiTx Therapeutics Inc (NASDAQ: ADTX) (announced introduction of AditxtScore for COVID-19 to be used in detecting...
Earnings Preview for Mersana Therapeutics
08:13pm, Thursday, 06'th Aug 2020
Mersana Therapeutics (NASDAQ: MRSN) releases its next round of earnings this Friday, August 07. Here's Benzinga's essential guide to Mersana Therapeutics's Q2 earnings report.Earnings and Revenue Base
DS Announces Clinical Trial Collaboration with AZ to Evaluate Patritumab Deruxtecan (U3-1402) in Combination with TAGRISSO in EGFR-Mutated NSCLC
Are Institutions Heavily Invested In Mersana Therapeutics, Inc.'s (NASDAQ:MRSN) Shares?
04:19pm, Tuesday, 04'th Aug 2020
A look at the shareholders of Mersana Therapeutics, Inc. (NASDAQ:MRSN) can tell us which group is most powerful...
Mersana Therapeutics to Present at Upcoming Investor Conferences
12:00pm, Tuesday, 04'th Aug 2020
CAMBRIDGE, Mass., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-dr
Stoke Therapeutics to Present at Upcoming Investor Conferences in August
11:30am, Tuesday, 04'th Aug 2020
Stoke Therapeutics, Inc., (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced t
Nisa Investment Advisors LLC Has $1.63 Million Stock Position in Agree Realty Co. (NYSE:ADC)
07:42am, Monday, 03'rd Aug 2020
Nisa Investment Advisors LLC boosted its holdings in shares of Agree Realty Co. (NYSE:ADC) by 122.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Co
